157 related articles for article (PubMed ID: 32560076)
1. Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging.
Liu HC; Gang EJ; Kim HN; Ruan Y; Ogana H; Wan Z; Bönig H; Shung KK; Kim YM
Cells; 2020 Jun; 9(6):. PubMed ID: 32560076
[TBL] [Abstract][Full Text] [Related]
2. Integrin Antibody Decreases Deformability of Patient-Derived Pre-B Acute Lymphocytic Leukemia Cells as Measured by High-Frequency Acoustic Tweezers.
Liu HC; Gang EJ; Kim HN; Abdel-Azim N; Chen R; Abdel-Azim H; Shung KK; Kim YM
J Ultrasound Med; 2020 Mar; 39(3):589-595. PubMed ID: 31633840
[TBL] [Abstract][Full Text] [Related]
3. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
[TBL] [Abstract][Full Text] [Related]
4. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Hsieh YT; Gang EJ; Geng H; Park E; Huantes S; Chudziak D; Dauber K; Schaefer P; Scharman C; Shimada H; Shojaee S; Klemm L; Parameswaran R; Loh M; Kang ES; Koo HH; Hofmann WK; Andrade J; Crooks GM; Willman CL; Müschen M; Papayannopoulou T; Heisterkamp N; Bönig H; Kim YM
Blood; 2013 Mar; 121(10):1814-8. PubMed ID: 23319569
[TBL] [Abstract][Full Text] [Related]
5. Heterotypic adherence between human B-lymphoblastic and pre-B-lymphoblastic cells and marrow stromal cells is a biphasic event: integrin very late antigen-4 alpha mediates only the early phase of the heterotypic adhesion.
Patrick CW; Juneja HS; Lee S; Schmalstieg FC; McIntire LV
Blood; 1995 Jan; 85(1):168-78. PubMed ID: 7528565
[TBL] [Abstract][Full Text] [Related]
6. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.
Shen W; Bendall LJ; Gottlieb DJ; Bradstock KF
Exp Hematol; 2001 Dec; 29(12):1439-47. PubMed ID: 11750103
[TBL] [Abstract][Full Text] [Related]
7. Adhesion of precursor-B acute lymphoblastic leukaemia cells to bone marrow stromal proteins.
Makrynikola V; Bradstock KF
Leukemia; 1993 Jan; 7(1):86-92. PubMed ID: 8418384
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.
Bendall LJ; Kortlepel K; Gottlieb DJ
Exp Hematol; 1997 Feb; 25(2):132-9. PubMed ID: 9015213
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of human laminin-8. Laminin-8 stimulates cell adhesion and migration through alpha3beta1 and alpha6beta1 integrins.
Fujiwara H; Kikkawa Y; Sanzen N; Sekiguchi K
J Biol Chem; 2001 May; 276(20):17550-8. PubMed ID: 11278628
[TBL] [Abstract][Full Text] [Related]
10. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
Gang EJ; Kim HN; Hsieh YT; Ruan Y; Ogana HA; Lee S; Pham J; Geng H; Park E; Klemm L; Willman CL; Carroll WL; Mittelman SD; Orgel E; Oberley MJ; Parekh C; Abdel-Azim H; Bhojwani D; Wayne AS; De Arcangelis A; Georges-Labouesse E; Wayner E; Bonig H; Minasyan A; Ten Hoeve J; Graeber TG; Müschen M; Heisterkamp N; Kim YM
Blood; 2020 Jul; 136(2):210-223. PubMed ID: 32219444
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts.
Bradstock K; Makrynikola V; Bianchi A; Byth K
Blood; 1993 Dec; 82(11):3437-44. PubMed ID: 7694686
[TBL] [Abstract][Full Text] [Related]
12. Characterization of heterotypic adherence between transformed human lymphoblastic cells and marrow stromal cells: VCAM-1 is a ligand for one of the leukemia cell adhesion proteins.
Juneja HS; Rajaraman S; Gay RE; Gay S; Schmalsteig FC
Exp Hematol; 1992 Dec; 20(11):1263-70. PubMed ID: 1283595
[TBL] [Abstract][Full Text] [Related]
13. Cell adhesion and motility depend on nanoscale RGD clustering.
Maheshwari G; Brown G; Lauffenburger DA; Wells A; Griffith LG
J Cell Sci; 2000 May; 113 ( Pt 10)():1677-86. PubMed ID: 10769199
[TBL] [Abstract][Full Text] [Related]
14. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease.
Bradstock KF; Gottlieb DJ
Leuk Lymphoma; 1995 Jun; 18(1-2):1-16. PubMed ID: 8580810
[TBL] [Abstract][Full Text] [Related]
15. New approaches to blockade of alpha4-integrins, proven therapeutic targets in chronic inflammation.
Kummer C; Ginsberg MH
Biochem Pharmacol; 2006 Nov; 72(11):1460-8. PubMed ID: 16870156
[TBL] [Abstract][Full Text] [Related]
16. Contribution of alpha6 integrins to hematopoietic stem and progenitor cell homing to bone marrow and collaboration with alpha4 integrins.
Qian H; Tryggvason K; Jacobsen SE; Ekblom M
Blood; 2006 May; 107(9):3503-10. PubMed ID: 16439681
[TBL] [Abstract][Full Text] [Related]
17.
Ruan Y; Kim HN; Ogana HA; Gang EJ; Li S; Liu HC; Bhojwani D; Wayne AS; Yang M; Kim YM
Exp Ther Med; 2022 Jan; 23(1):47. PubMed ID: 34934426
[TBL] [Abstract][Full Text] [Related]
18. Functional differences between integrin alpha4 and integrins alpha5/alphav in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin.
Zhang Y; Lu H; Dazin P; Kapila Y
Exp Cell Res; 2004 Apr; 295(1):48-58. PubMed ID: 15051489
[TBL] [Abstract][Full Text] [Related]
19. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
